🧠 7 Student Memory Support - AI Learning Cycle

Gastrointestinal System (GIT) — Year 2 MBBS

🧠 Step 8 — Student Memory Support

This final section is designed for rapid revision, memory strengthening, and last-day exam preparation. Use it after completing the topic to recall high-yield facts quickly.

🎯 How to Use This Section

Revise flashcards for quick recall.
Use mnemonics to remember lists.
Review memory tables for comparison-based questions.
Read clinical hooks before exams.
Mark the topic complete after revision.

🃏 1️⃣ High-Yield Flashcards

What is the major precursor of eicosanoids?

Arachidonic acid.

Which enzyme releases arachidonic acid from membrane phospholipids?

Phospholipase A₂.

Which pathway forms prostaglandins and thromboxanes?

Cyclo-oxygenase (COX) pathway.

Which pathway forms leukotrienes?

Lipoxygenase (LOX) pathway.

Which COX isoform mainly protects gastric mucosa?

COX-1.

Which COX isoform is induced during inflammation?

COX-2.

Which prostanoid promotes platelet aggregation?

Thromboxane A₂ (TXA₂).

Which prostanoid inhibits platelet aggregation?

Prostacyclin (PGI₂).

Which drug irreversibly inhibits COX enzyme?

Aspirin.

Which leukotriene is important in neutrophil chemotaxis?

LTB₄.

Which drugs block leukotriene receptors?

Montelukast and zafirlukast.

Which drug inhibits 5-lipoxygenase?

Zileuton.

🧠 2️⃣ Mnemonics

Mnemonic Title:

COX Functions

Mnemonic Word:
“COX Protects & Inflames”

Meaning:

COX-1 → Protects stomach and platelets
COX-2 → Inflammation and pain

Mnemonic Title:

Leukotriene Effects

Mnemonic Word:
“B4 Brings Neutrophils”

Meaning:

LTB₄ → Neutrophil chemotaxis

Mnemonic Title:

Asthma Drugs

Mnemonic Word:
“MONTE blocks, ZILE stops”

Meaning:

Montelukast → blocks leukotriene receptors
Zileuton → stops leukotriene synthesis

📋 3️⃣ Memory Tables

Table 1 — COX-1 vs COX-2

Feature	COX-1	COX-2
Type	Constitutive	Inducible
Main Role	Gastric protection	Inflammation
Platelet Function	Present	Minimal
Drug Effect	Ulcer risk if inhibited	Anti-inflammatory target

Table 2 — Prostacyclin vs Thromboxane

Feature	Prostacyclin (PGI₂)	Thromboxane A₂
Source	Endothelium	Platelets
Vessel Effect	Vasodilation	Vasoconstriction
Platelets	Inhibits aggregation	Promotes aggregation

⚡ 4️⃣ Rapid Revision Points

Must Remember:

• Eicosanoids are derived from arachidonic acid.
• Phospholipase A₂ releases arachidonic acid.
• COX pathway forms prostaglandins and thromboxanes.
• LOX pathway forms leukotrienes.
• COX-1 protects gastric mucosa.
• COX-2 mediates inflammation.
• Aspirin irreversibly inhibits COX.
• NSAIDs commonly cause gastric ulceration.
• Leukotrienes cause bronchoconstriction.
• Montelukast blocks leukotriene receptors.
• Zileuton inhibits 5-lipoxygenase.
• Prostanoids have short half-life.

🩺 5️⃣ Clinical Memory Hooks

Clinical Hook:

Bronchial asthma → Excess leukotriene activity.

Clinical Hook:

Peptic ulcer disease → Loss of protective prostaglandins after NSAID use.

Clinical Hook:

Myocardial infarction prevention → Aspirin inhibits platelet TXA₂ synthesis.

Clinical Hook:

Aspirin-sensitive asthma → COX inhibition shifts pathway toward leukotrienes.

Clinical Hook:

Long-term steroid therapy → Osteoporosis and immunosuppression.

6️⃣ Do’s, Don’ts & ⚠️ Common Mistakes

✅ Do’s

• Do remember COX-1 is protective.
• Do connect leukotrienes with asthma.
• Do correlate aspirin with irreversible COX inhibition.
• Do remember PGI₂ and TXA₂ have opposite actions.
• Do revise drug targets in the arachidonic acid pathway.

❌ Don’ts

• Don’t confuse COX pathway with LOX pathway.
• Don’t label leukotrienes as prostaglandins.
• Don’t forget steroids act upstream of COX and LOX.
• Don’t confuse prostacyclin with thromboxane.
• Don’t assume all NSAIDs act irreversibly.

⚠️ Common Mistakes

• Confusing COX-1 with inflammatory COX-2.
• Forgetting aspirin irreversibly inhibits platelets.
• Mixing up montelukast and zileuton mechanisms.
• Assuming leukotrienes cause vasodilation.
• Forgetting prostanoids are rapidly degraded locally.

Enable Notifications OK No thanks